$232 Million is the total value of HARBOURVEST PARTNERS LLC's 28 reported holdings in Q2 2020. The portfolio turnover from Q1 2020 to Q2 2020 was 38.9% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| SWI | Solarwinds Corp. | $139,112,000 | +12.8% | 7,872,801 | 0.0% | 59.96% | +0.7% | |
| AXLA | Buy | Axcella Health, Inc. | $15,528,000 | +269.5% | 2,807,981 | +128.5% | 6.69% | +229.9% |
| EVLO | Buy | Evelo Biosciences, Inc. | $15,011,000 | +126.7% | 3,063,505 | +73.7% | 6.47% | +102.4% |
| KLDO | Buy | Kaliedo Biosciences, Inc. | $13,625,000 | +89.8% | 1,833,832 | +57.1% | 5.87% | +69.5% |
| WORK | Sell | Slack Technologies, Inc. | $8,871,000 | -54.3% | 285,325 | -60.6% | 3.82% | -59.2% |
| FNJN | Finjan Holdings, Inc. | $6,627,000 | +54.0% | 4,303,435 | 0.0% | 2.86% | +37.5% | |
| RUBY | Rubius Therapeutics, Inc. | $5,902,000 | +34.4% | 986,878 | 0.0% | 2.54% | +20.0% | |
| PINS | Sell | Pinterest, Inc. | $4,685,000 | -42.6% | 211,336 | -60.0% | 2.02% | -48.8% |
| SONO | Sonos, Inc. | $4,437,000 | +72.5% | 303,253 | 0.0% | 1.91% | +53.9% | |
| ZUO | Zuora, Inc. | $2,389,000 | +58.4% | 187,386 | 0.0% | 1.03% | +41.5% | |
| LC | LendingClub Corp. | $2,336,000 | -42.0% | 513,440 | 0.0% | 1.01% | -48.3% | |
| YEXT | Yext, Inc. | $1,913,000 | +63.1% | 115,147 | 0.0% | 0.82% | +45.8% | |
| SFIX | Stitchfix, Inc. | $1,660,000 | +96.4% | 66,571 | 0.0% | 0.72% | +75.5% | |
| LOV | Spark Networks SEsponsored adr | $1,659,000 | +27.9% | 502,576 | 0.0% | 0.72% | +14.2% | |
| TENB | New | Tenable Holdings, Inc. | $1,653,000 | – | 55,444 | +100.0% | 0.71% | – |
| ISEE | New | IVERIC Bio, Inc. | $1,574,000 | – | 308,540 | +100.0% | 0.68% | – |
| PS | PluralSight, Inc. | $958,000 | +64.3% | 53,057 | 0.0% | 0.41% | +47.0% | |
| LYFT | Lyft, Inc. | $851,000 | +23.0% | 25,785 | 0.0% | 0.37% | +9.9% | |
| CTMX | Cytomx Therapeutics, Inc. | $660,000 | +8.7% | 79,193 | 0.0% | 0.28% | -3.1% | |
| PTI | Proteostasis Therapeutics, Inc. | $604,000 | +20.3% | 440,627 | 0.0% | 0.26% | +7.4% | |
| EPZM | New | Epizyme, Inc. | $396,000 | – | 24,686 | +100.0% | 0.17% | – |
| TRVN | Trevena, Inc. | $351,000 | +163.9% | 233,850 | 0.0% | 0.15% | +135.9% | |
| AR | Antero Resources LLC | $335,000 | +256.4% | 131,895 | 0.0% | 0.14% | +220.0% | |
| XGN | Exagen, Inc. | $322,000 | -22.2% | 25,982 | 0.0% | 0.14% | -30.5% | |
| CSLT | Castlight Health, Inc. | $290,000 | +15.1% | 349,070 | 0.0% | 0.12% | +2.5% | |
| NXTC | NextCure, Inc. | $215,000 | -42.2% | 10,044 | 0.0% | 0.09% | -48.3% | |
| METC | Ramaco Resources, Inc. | $32,000 | -11.1% | 14,951 | 0.0% | 0.01% | -17.6% | |
| HNRG | Hallador Energy Resources, Inc. | $9,000 | -35.7% | 14,270 | 0.0% | 0.00% | -42.9% | |
| XSPA | Exit | XpresSpa Group, Inc | $0 | – | -102,912 | -100.0% | -0.01% | – |
| UPWK | Exit | Upwork, Inc. | $0 | – | -56,126 | -100.0% | -0.18% | – |
| MGI | Exit | MoneyGram Internation, Inc. | $0 | – | -565,893 | -100.0% | -0.36% | – |
| RYTM | Exit | Rhythm Pharmaceuticals, Inc. | $0 | – | -50,221 | -100.0% | -0.37% | – |
| REAL | Exit | RealReal, Inc. | $0 | – | -116,158 | -100.0% | -0.39% | – |
| KALA | Exit | Kala Pharmaceuticals, Inc. | $0 | – | -99,186 | -100.0% | -0.42% | – |
| CRWD | Exit | CrowdStrike Holdings, Inc. | $0 | – | -15,667 | -100.0% | -0.42% | – |
| PD | Exit | PagerDuty, Inc. | $0 | – | -54,222 | -100.0% | -0.45% | – |
| ALRM | Exit | Alarm.com Holdings, Inc. | $0 | – | -52,796 | -100.0% | -0.99% | – |
| PRTS | Exit | U.S. Auto Parts Network, Inc. | $0 | – | -1,476,877 | -100.0% | -1.25% | – |
| FSLY | Exit | Fastly, Inc. | $0 | – | -229,771 | -100.0% | -2.10% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2020-08-13
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| Wayfair, Inc. | 25 | Q3 2023 | 83.5% |
| Trevena, Inc. | 25 | Q4 2021 | 1.2% |
| Finjan Holdings, Inc. | 23 | Q2 2020 | 18.5% |
| Zuora, Inc. | 21 | Q3 2023 | 3.4% |
| Evelo Biosciences, Inc. | 20 | Q1 2023 | 26.3% |
| CytomX Therpeutics, Inc. | 19 | Q4 2021 | 2.3% |
| LendingClub Corp. | 18 | Q3 2019 | 11.9% |
| Rubius Therapeutics, Inc. | 18 | Q4 2022 | 21.4% |
| Solarwinds Corp. | 17 | Q4 2022 | 60.4% |
| Axcella Health, Inc. | 17 | Q2 2023 | 6.7% |
View HARBOURVEST PARTNERS LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| SolarWinds Corp | February 14, 2022 | 3,719,600 | 2.3% |
| N-able, Inc. | December 20, 2021 | 3,719,600 | 2.1% |
| OncoMed Pharmaceuticals Inc | February 14, 2019 | 1,901,106 | 4.9% |
| Wayfair Inc. | February 16, 2016 | 2,115,296 | 4.6% |
| ENVIVIO INC | February 13, 2013 | 3,639,939 | 13.5% |
| NETWORK ENGINES INCSold out | February 13, 2013 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | August 06, 2010 | 243,689 | 2.1% |
| CERAGON NETWORKS LTDSold out | July 26, 2007 | 0 | 0.0% |
| VISTAPRINT LTDSold out | February 14, 2007 | 0 | 0.0% |
| VOCALTEC COMMUNICATIONS LTD | May 26, 2006 | 1,218,444 | 24.4% |
View HARBOURVEST PARTNERS LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 40-APP | 2024-04-24 |
| 13F-HR | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| 13F-HR | 2022-11-14 |
| 13F-HR | 2022-08-15 |
| 13F-HR/A | 2022-05-26 |
| 13F-HR | 2022-05-13 |
View HARBOURVEST PARTNERS LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.